Metal and metal oxide nanoparticles to enhance the performance of enzyme-linked immunosorbent assay (ELISA)
Enzyme-linked immunosorbent assay (ELISA) is a technique designed for the detection and
quantification of (bio) molecules in a liquid sample. It is a powerful tool in clinical …
quantification of (bio) molecules in a liquid sample. It is a powerful tool in clinical …
Expression and detection of anti-HBs antibodies after hepatitis B virus infection or vaccination in the context of protective immunity
RAA Pondé - Archives of Virology, 2019 - Springer
Anti-HBs antibodies develop after natural infection with hepatitis B virus (HBV) or
vaccination against this virus, as a result of activation of the human immune system by the …
vaccination against this virus, as a result of activation of the human immune system by the …
Enzyme-linked immunosorbent assay versus chemiluminescent immunoassay: A general overview
Enzyme-linked immunosorbent assay (ELISA) technique measures antigens, antibodies,
and protein reactions in biological samples by enzymatic reactions. The chemiluminescence …
and protein reactions in biological samples by enzymatic reactions. The chemiluminescence …
Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis
Abstract Background Hepatitis B virus (HBV) infection in Africa is mostly acquired before the
age of 5 years through vertical or horizontal routes. While all the countries in the World …
age of 5 years through vertical or horizontal routes. While all the countries in the World …
[HTML][HTML] A prospective study on rapidly declining SARS‐CoV‐2 IgG antibodies within one to three months of testing IgG positive: can it lead to potential reinfections?
Background COVID-19 immunoglobulin G (IgG) antibodies have been considered to provide
protective immunity and its immunoassays have been widely used for serosurveillance. In …
protective immunity and its immunoassays have been widely used for serosurveillance. In …
A retrospective serological survey of hepatitis B virus infection in Northeast China
J Meng, H Xu, D Sui, J Jiang, J Li, Y Gao, J Niu - BMC infectious diseases, 2019 - Springer
Abstract Background Hepatitis B virus (HBV) infection is a major public health burden in
China although it has steadily declined over the last two decades. A valid updated …
China although it has steadily declined over the last two decades. A valid updated …
Comparison of three serological chemiluminescence immunoassays for SARS-CoV-2, and clinical significance of antibody index with disease severity
N Lee, S Jeong, MJ Park, W Song - PLoS One, 2021 - journals.plos.org
Background The clinical significance of the quantitative value of antibodies in severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains mostly unidentified. We …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains mostly unidentified. We …
Head-to-head comparison of Enzyme Linked Immunosorbent Assay (ELISA) and Enhanced Chemiluminescence Immunoassay (ECLIA) for the detection of …
AK Tiwari, AP Upadhyay, D Arora, T Wadhwa… - Journal of virological …, 2020 - Elsevier
Safe blood transfusion being the cornerstone of any Blood Transfusion Services requires
meticulous testing for Transfusion Transmitted Disease (TTD) markers in donated blood. We …
meticulous testing for Transfusion Transmitted Disease (TTD) markers in donated blood. We …
Rapid detection system for hepatitis B surface antigen (HBsAg) based on immunomagnetic separation, multi-angle dynamic light scattering and support vector …
Hepatitis B virus (HBV) is a significant public health problem worldwide. Hepatitis B surface
antigen (HBsAg) is the principle marker for laboratory testing of HBV, but the rapid …
antigen (HBsAg) is the principle marker for laboratory testing of HBV, but the rapid …
Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low-and Middle-Income Countries
To achieve the World Health Organization's (WHO) goals of eradicating viral hepatitis
globally by 2030, the regional prevalence and epidemiology of hepatitis B virus (HBV) and …
globally by 2030, the regional prevalence and epidemiology of hepatitis B virus (HBV) and …